Company Search:
Advanced Search
Sponsored Links
Akebia Therapeutics Inc Company Snapshot
Akebia Therapeutics Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Akebia Therapeutics Inc with three other companies in this sector in UNITED STATES : Intercept Pharmaceuticals Inc (2020 sales of $312.69 million of which 100% was Biopharmaceutical), Collegium Pharmaceutical Inc ($310.02 million of which 59% was Nucynta), and Ultragenyx Pharmaceutical Inc ($271.03 million of which 47% was -share territory).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Akebia Therapeutics Inc
  Stock Performance Chart for Akebia Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 3.67
(Figures in U.S. Dollars)
1 Week 9.2%   13 Weeks 6.4%  
4 Weeks 1.7%   52 Weeks -67.2%  
Akebia Therapeutics Inc Key Data:
  Ticker: AKBA Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 295,307,000
(Year Ending Jan 2021).
Employees: 380
  Currency: U.S. Dollars Market Cap: 581,768,727
  Fiscal Yr Ends: December Shares Outstanding: 158,520,089
  Share Type: Ordinary Closely Held Shares: 1,765,570
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.